Risk Factors for the Development of Cardiac Arrhythmias during Hematopoietic Stem Cell Transplantation
Conclusion: Our data suggests that a diagnosis of Non-Hodgkin's Lymphoma or QTc prolongation ≥ 500 msec at any time during HSCT may be risk factors for CA during HSCT. Our study has the limitation of being a single institution analysis however, most patients (70%) in this analysis were prospectively placed on cardiac telemetry making our assessment of the incidence of CA during HSCT reliably accurate. Prospective interventional studies are warrant.[1] Tonorezos, Emilys S; Stillwell, Elizabth E; Calloway, James J., et al., Bone Marrow Transplant. 2015 Sep; 50(9): 1212-1216.[2] Osranek M, Fatema K, Qaddoura F, et al. Left atrial volume predicts the risk of atrial fibrillation after cardiac surgery: a prospective study. J Am Coll Cardiol. 2006;48(4):779-786.[3] Garcia I., Rodriguez T.E., Davis S., et al.; The Necessity of MUGA Scans to Detect Risks for Cardiac Toxicity in Patients Considered for Bone Marrow Transplantation. Tandem IBMTR/ASBMT Meeting; Orlando, FL 2002.DisclosuresNo relevant conflicts of interest to declare.
Source: Blood - Category: Hematology Authors: Kapolas, C., Kosirog-Glowacki, J., Barney, K. L., Advincula, L., Klein, L. M., Bitran, J. D., Bufalino, S., Rodriguez, T. E. Tags: 721. Clinical Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Transplant Toxicities: Poster II Source Type: research
More News: Amyloidosis | Arrhythmia | Atrial Fibrillation | Bone Marrow Transplant | Cardiac Arrhythmia | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Chronic Kidney Disease | Congestive Heart Failure | Diabetes | Diabetes Mellitus | Endocrinology | Heart | Heart Failure | Heart Transplant | Hodgkin's Disease | Hypertension | Kidney Transplant | Kidney Transplantation | Lymphoma | Non-Hodgkin's Lymphoma | PET Scan | Smokers | Statistics | Stem Cell Therapy | Stem Cells | Study | Toxicology | Transplant Surgery | Transplants | Urology & Nephrology